These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10852638)

  • 1. Clinical potential of matrix metalloprotease inhibitors in cancer therapy.
    Heath EI; Grochow LB
    Drugs; 2000 May; 59(5):1043-55. PubMed ID: 10852638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase inhibitors: do they have a place in anticancer therapy?
    Rudek MA; Venitz J; Figg WD
    Pharmacotherapy; 2002 Jun; 22(6):705-20. PubMed ID: 12066962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of matrix metalloproteinase inhibitors in cancer therapy.
    Hidalgo M; Eckhardt SG
    J Natl Cancer Inst; 2001 Feb; 93(3):178-93. PubMed ID: 11158186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinase inhibitors: applications in oncology.
    Yip D; Ahmad A; Karapetis CS; Hawkins CA; Harper PG
    Invest New Drugs; 1999; 17(4):387-99. PubMed ID: 10759405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment.
    Zucker S; Cao J; Chen WT
    Oncogene; 2000 Dec; 19(56):6642-50. PubMed ID: 11426650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinase inhibitors.
    Ramnath N; Creaven PJ
    Curr Oncol Rep; 2004 Mar; 6(2):96-102. PubMed ID: 14751086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ongoing trials with matrix metalloproteinase inhibitors.
    Brown PD
    Expert Opin Investig Drugs; 2000 Sep; 9(9):2167-77. PubMed ID: 11060801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase inhibitors: present achievements and future prospects.
    Denis LJ; Verweij J
    Invest New Drugs; 1997; 15(3):175-85. PubMed ID: 9387040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase inhibitors and cancer: trials and tribulations.
    Coussens LM; Fingleton B; Matrisian LM
    Science; 2002 Mar; 295(5564):2387-92. PubMed ID: 11923519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiprotease therapy in cancer: hot or not?
    Lah TT; Durán Alonso MB; Van Noorden CJ
    Expert Opin Biol Ther; 2006 Mar; 6(3):257-79. PubMed ID: 16503735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical and clinical studies of MMP inhibitors in cancer.
    Drummond AH; Beckett P; Brown PD; Bone EA; Davidson AH; Galloway WA; Gearing AJ; Huxley P; Laber D; McCourt M; Whittaker M; Wood LM; Wright A
    Ann N Y Acad Sci; 1999 Jun; 878():228-35. PubMed ID: 10415734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases. Novel targets for directed cancer therapy.
    Yu AE; Hewitt RE; Connor EW; Stetler-Stevenson WG
    Drugs Aging; 1997 Sep; 11(3):229-44. PubMed ID: 9303281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase inhibitors for cancer therapy:the current situation and future prospects.
    Fingleton B
    Expert Opin Ther Targets; 2003 Jun; 7(3):385-97. PubMed ID: 12783574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marimastat: the clinical development of a matrix metalloproteinase inhibitor.
    Steward WP; Thomas AL
    Expert Opin Investig Drugs; 2000 Dec; 9(12):2913-22. PubMed ID: 11093361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy.
    Overall CM; Kleifeld O
    Nat Rev Cancer; 2006 Mar; 6(3):227-39. PubMed ID: 16498445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical studies with matrix metalloproteinase inhibitors.
    Brown PD
    APMIS; 1999 Jan; 107(1):174-80. PubMed ID: 10190295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase inhibitors.
    Brown PD
    Breast Cancer Res Treat; 1998; 52(1-3):125-36. PubMed ID: 10066077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural bio-drugs as matrix metalloproteinase inhibitors: new perspectives on the horizon?
    Mannello F
    Recent Pat Anticancer Drug Discov; 2006 Jan; 1(1):91-103. PubMed ID: 18221029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MMP inhibitors: experimental and clinical studies.
    Belotti D; Paganoni P; Giavazzi R
    Int J Biol Markers; 1999; 14(4):232-8. PubMed ID: 10669951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical potential of matrix metalloprotease inhibitors.
    Wojtowicz-Praga S
    Drugs R D; 1999 Feb; 1(2):117-29. PubMed ID: 10566004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.